世界の血液分析装置市場:医療機器パイプライン分析2016

◆英語タイトル:Haematology Analyzers - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0214EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年8月1日
◆ページ数:113
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、血液分析装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・血液分析装置の概要
・血液分析装置の開発動向:開発段階別分析
・血液分析装置の開発動向:セグメント別分析
・血液分析装置の開発動向:領域別分析
・血液分析装置の開発動向:規制Path別分析
・血液分析装置の開発動向:承認日(推定)別分析
・企業別血液分析装置の開発動向(パイプライン製品、進行中の治験)
・血液分析装置の最近動向
【レポートの概要】

Haematology Analyzers – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Haematology Analyzers – Medical Devices Pipeline Assessment, 2016″ provides an overview of Haematology Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Haematology Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Haematology Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Haematology Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Haematology Analyzers Overview 9
3 Products under Development 10
3.1 Haematology Analyzers – Pipeline Products by Stage of Development 10
3.2 Haematology Analyzers – Pipeline Products by Territory 11
3.3 Haematology Analyzers – Pipeline Products by Regulatory Path 12
3.4 Haematology Analyzers – Pipeline Products by Estimated Approval Date 13
4 Haematology Analyzers – Pipeline Products under Development by Companies 14
4.1 Haematology Analyzers Companies – Pipeline Products by Stage of Development 14
4.2 Haematology Analyzers – Pipeline Products by Stage of Development 16
5 Haematology Analyzers Companies and Product Overview 17
5.1 Abbott Diagnostics Company Overview 17
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Analyticon Biotechnologies AG Company Overview 18
5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Apollo Medical Devices LLC Company Overview 21
5.3.1 Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Arkray, Inc. Company Overview 22
5.4.1 Arkray, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Auer Precision Company Overview 23
5.5.1 Auer Precision Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Axxin Company Overview 24
5.6.1 Axxin Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Baebies, Inc. Company Overview 25
5.7.1 Baebies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 Columbia University Company Overview 26
5.8.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 DiaSorin S.p.A Company Overview 27
5.9.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 Diatron Medical Instruments Limited Company Overview 29
5.10.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Drew Scientific Co. Limited Company Overview 30
5.11.1 Drew Scientific Co. Limited Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 Ionu Biosystems Company Overview 32
5.12.1 Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 IRIS International, Inc. Company Overview 33
5.13.1 IRIS International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 Mindray Medical International Limited Company Overview 34
5.14.1 Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.15 Noninvasix, Inc. Company Overview 37
5.15.1 Noninvasix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.16 Quotient Limited Company Overview 38
5.16.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 38
5.17 Roche Diagnostics International Ltd. Company Overview 40
5.17.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.18 SigTuple Technologies Private Limited Company Overview 43
5.18.1 SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 SpinChip Diagnostics AS Company Overview 44
5.19.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 Sysmex Corporation Company Overview 45
5.20.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 T2 Biosystems, Inc. Company Overview 46
5.21.1 T2 Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 Tarabios Company Overview 48
5.22.1 Tarabios Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 The University of British Columbia Company Overview 49
5.23.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 49
5.24 University of Barcelona Company Overview 51
5.24.1 University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Visca Corporation Company Overview 52
5.25.1 Visca Corporation Pipeline Products & Ongoing Clinical Trials Overview 52
6 Haematology Analyzers- Recent Developments 53
6.1 Jul 16, 2016: Alere initiating voluntary withdrawal of Alere INRatio and INRatio 2 PT/INR Monitoring System that may pose serious health risks 53
6.2 Jul 15, 2016: CellaVision: Interim Report January-June 2016 53
6.3 Jul 11, 2016: Quotient Provides Update on the MosaiQ Development Plan 55
6.4 Jul 11, 2016: Quotient Reports Preliminary Fiscal First Quarter 2017 Revenues 57
6.5 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director 57
6.6 Jul 08, 2016: Reed Construction Selected To Complete New Medline Headquarters 58
6.7 Jun 28, 2016: InDevR Appoints Dawn Bitz as Chief Commercial Officer 58
6.8 Jun 27, 2016: Medline and Medic Management Group Launch New GPO Distribution Partnership 59
6.9 Jun 24, 2016: Genome British Columbia Investing in Companies and Jobs Through e@UBC 59
6.10 Jun 23, 2016: ORTHO VISION Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting 60
6.11 Jun 21, 2016: MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims 60
6.12 Jun 20, 2016: Sysmex Canada to Distribute CellaVision Systems 61
6.13 Jun 17, 2016: Daxor Announces Hiring of Chief Financial Officer 61
6.14 Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 62
6.15 Jun 13, 2016: EKF Diagnostics’ Quo-Test HbA1c analyzer achieves class leading level of performance 62
6.16 Jun 01, 2016: Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award for Development of the TEG 6s 62
6.17 May 31, 2016: ERBA Diagnostics Announces Extension of CEO’S Contract Term and Appointment of Hayden Jeffreys to Board of Directors 63
6.18 May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health’s Physician Offices Results in Cost Savings of 10 Percent 63
6.19 May 23, 2016: Quotient Reports Continued Progress on the Development of MosaiQ and Fourth Quarter and Fiscal Year 2016 Financial Results 64
6.20 May 20, 2016: ERBA Diagnostics Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan 67
6.21 May 19, 2016: Medline Inks Three-Year Prime Vendor Distribution Agreement with SBH Health System 68
6.22 May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results 68
6.23 May 09, 2016: EKF Diagnostics Announces Directorate Change 69
6.24 May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance 69
6.25 May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer 70
6.26 Apr 28, 2016: Ortho Clinical Diagnostics Announces Availability of ORTHO Sera Extended Phenotype Testing on ORTHO VISION Analyzer for BioVue Cassettes 71
6.27 Apr 28, 2016: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016 71
6.28 Apr 28, 2016: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016 and Declares a 9% Increase in Quarterly Cash Dividend 73
6.29 Apr 26, 2016: MD Anderson Cancer Center to acquire Elekta linear accelerators and other radiotherapy solutions 75
6.30 Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change 75
6.31 Apr 13, 2016: Quotient Announces Positive MosaiQ Serological Disease Screening Results 76
6.32 Apr 06, 2016: Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume Analysis: New Data Presented at the American College of Cardiology Congress 77
6.33 Mar 24, 2016: Baron & Budd Investigating Claims Involving the Alere INRatio Blood-Testing System 78
6.34 Mar 23, 2016: STRATEC Biomedical to Acquire Diatron from Riverside Company 78
6.35 Mar 09, 2016: University of Hawaii and The Queen’s Medical Center Reports on a Study on Critically Ill Patients Utilizing Blood Volume Measurement and Pulmonary Artery Catheterization 79
6.36 Mar 01, 2016: HORIBA: Alliance’2016 79
6.37 Feb 29, 2016: Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent Developments 80
6.38 Feb 22, 2016: Sysmex America Enters into Distribution Agreement with Medline Industries 81
6.39 Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results 81
6.40 Feb 09, 2016: HORIBA Formulates New Mid-Long Term Management Plan MLMAP2020 82
6.41 Feb 08, 2016: Daxor Announces Sale of BVA-100 Blood Volume Analyzer to Nebraska Medicine 83
6.42 Feb 08, 2016: Quotient Reports Third Quarter Fiscal 2016 Financial Results 83
6.43 Jan 28, 2016: Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2016, Declares Quarterly Cash Dividend 87
6.44 Jan 11, 2016: Quotient Announces Positive Serological Disease Screening Results and Provides MosaiQ Development Program Update 88
6.45 Dec 10, 2015: Daxor Announces an Increased Dividend and the Appointment of Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis 90
6.46 Dec 01, 2015: Sysmex Establishes New Subsidiary in Ghana – Reinforcing the Company’s Business Foundation in the Markets of West and Central Africa 90
6.47 Nov 16, 2015: Escalon Medical Reports First Quarter Fiscal 2016 Results 91
6.48 Nov 13, 2015: Mindray Announces Third Quarter 2015 Financial Results 91
6.49 Nov 12, 2015: Terre Haute Regional Hospital Becomes First to Install the Ortho Clinical Diagnostics Ortho Vision Analyzer 94
6.50 Oct 27, 2015: Abaxis Reports Financial Performance for the Second Quarter of Fiscal 2016 94
6.51 Oct 22, 2015: Trinity Biotech announces Quarter 3 Financial Results 95
6.52 Oct 14, 2015: Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION Max Analyzer for High-Volume Transfusion Medicine Labs 97
6.53 Oct 02, 2015: Heart Failure Research from the Mayo Clinic Utilizing the BVA-100 Blood Volume Analyzer presented at the Annual Heart Failure Society of America Meeting 98
6.54 Oct 01, 2015: David Pacitti to Lead Siemens Healthcare North America Regional Organization 99
6.55 Sep 28, 2015: Escalon Medical Reports Fiscal 2015 Results 99
6.56 Sep 24, 2015: Diatron to introduce a revolutionary approach to hematology analysis at Medica 2015 100
6.57 Sep 15, 2015: Sysmex to Expand U.S. Reagent Factory – Aiming to Meet Growing Demand in the Americas 100
6.58 Sep 07, 2015: Transasia Bio-Medicals Plans to Raise Funds through IPO 101
6.59 Aug 28, 2015: Precision System Science to Raise USD11 Million in Public Offering of Shares 101
6.60 Aug 28, 2015: Precision System Science to Raise USD1.5 Million in Private Placement of Shares 101
6.61 Aug 18, 2015: Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION Analyzer, Making it Commercially Available in the United States 101
6.62 Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies 102
6.63 Aug 10, 2015: Mindray Announces Second Quarter 2015 Financial Results 102
6.64 Aug 03, 2015: Bio-Rad Introduces the IH-500, a Fully Automated Random Access System for Blood Typing and Screening 105
6.65 Aug 03, 2015: Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 106
6.66 Jul 31, 2015: Tokuyama Announces Consolidated Results For Q1 FY2015 106
6.67 Jul 30, 2015: Mindray’s Latest IVD Inventions Showcased at AACC 2015 109
7 Appendix 110
7.1 Methodology 110
7.2 About GlobalData 112
7.3 Contact Us 112
7.4 Disclaimer 113

1.1 List of Tables
Table 1: Haematology Analyzers - Pipeline Products by Stage of Development 10
Table 2: Haematology Analyzers - Pipeline Products by Territory 11
Table 3: Haematology Analyzers - Pipeline Products by Regulatory Path 12
Table 4: Haematology Analyzers - Pipeline Products by Estimated Approval Date 13
Table 5: Haematology Analyzers Companies - Pipeline Products by Stage of Development 14
Table 6: Haematology Analyzers - Pipeline Products by Stage of Development 16
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 17
Table 8: Next Generation Hematology Analyzer - Product Status 17
Table 9: Next Generation Hematology Analyzer - Product Description 17
Table 10: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 18
Table 11: Hemolyzer 3 Pro - Product Status 18
Table 12: Hemolyzer 3 Pro - Product Description 19
Table 13: Hemolyzer 5 - Product Status 19
Table 14: Hemolyzer 5 - Product Description 20
Table 15: Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 16: Point-Of-Care Blood Analyzer - Product Status 21
Table 17: Point-Of-Care Blood Analyzer - Product Description 21
Table 18: Arkray, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 19: ADAMS A1c Lite HA-8380V - Product Status 22
Table 20: ADAMS A1c Lite HA-8380V - Product Description 22
Table 21: Auer Precision Pipeline Products & Ongoing Clinical Trials Overview 23
Table 22: Blood Separation Microfluidic Device - Product Status 23
Table 23: Blood Separation Microfluidic Device - Product Description 23
Table 24: Axxin Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: Burnet AX-2 CD4 Test Reader - Product Status 24
Table 26: Burnet AX-2 CD4 Test Reader - Product Description 24
Table 27: Baebies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: FINDER - Product Status 25
Table 29: FINDER - Product Description 25
Table 30: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Microfluidic Device - Coagulation Dysfunction - Product Status 26
Table 32: Microfluidic Device - Coagulation Dysfunction - Product Description 26
Table 33: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: LIAISON IAM - Product Status 27
Table 35: LIAISON IAM - Product Description 28
Table 36: Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 29
Table 37: 3-part Differential Hematology Analyzer - Product Status 29
Table 38: 3-part Differential Hematology Analyzer - Product Description 29
Table 39: Drew Scientific Co. Limited Pipeline Products & Ongoing Clinical Trials Overview 30
Table 40: DS360 HbA1c Analyzer - Product Status 30
Table 41: DS360 HbA1c Analyzer - Product Description 31
Table 42: Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: Fluorescent Smart Phone Blood Analyzer - Product Status 32
Table 44: Fluorescent Smart Phone Blood Analyzer - Product Description 32
Table 45: IRIS International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: 3GEMS Hematology Analyzer - Product Status 33
Table 47: 3GEMS Hematology Analyzer - Product Description 33
Table 48: Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 34
Table 49: BC-20s - Product Status 34
Table 50: BC-20s - Product Description 34
Table 51: BC-30s - Product Status 35
Table 52: BC-30s - Product Description 35
Table 53: BC-5000 Hematology Analyzer - Product Status 35
Table 54: BC-5000 Hematology Analyzer - Product Description 36
Table 55: Noninvasix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 56: Optoacoustic-Based Non-Invasive Blood Diagnostic Device - Product Status 37
Table 57: Optoacoustic-Based Non-Invasive Blood Diagnostic Device - Product Description 37
Table 58: Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 38
Table 59: MosaiQ - Product Status 38
Table 60: MosaiQ - Product Description 39
Table 61: Quant-Rho For Cell Analyzer - Product Status 39
Table 62: Quant-Rho For Cell Analyzer - Product Description 39
Table 63: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: cobas m 511 - Bloodhound System - Product Status 40
Table 65: cobas m 511 - Bloodhound System - Product Description 41
Table 66: Cobas m511 System - Product Status 41
Table 67: Cobas m511 System - Product Description 42
Table 68: SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 43
Table 69: Shonit - Product Status 43
Table 70: Shonit - Product Description 43
Table 71: SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 44
Table 72: SpinChip - Product Status 44
Table 73: SpinChip - Product Description 44
Table 74: Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
Table 75: Liquid Biopsy System - Product Status 45
Table 76: Liquid Biopsy System - Product Description 45
Table 77: T2 Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 78: T2Plex - Product Status 46
Table 79: T2Plex - Product Description 47
Table 80: Tarabios Pipeline Products & Ongoing Clinical Trials Overview 48
Table 81: Benchtop System - Blood Screen - Product Status 48
Table 82: Benchtop System - Blood Screen - Product Description 48
Table 83: The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 49
Table 84: Portable Hematology Analyzer - Product Status 49
Table 85: Portable Hematology Analyzer - Product Description 50
Table 86: University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview 51
Table 87: Micro - rheometer - Product Status 51
Table 88: Micro - rheometer - Product Description 51
Table 89: Visca Corporation Pipeline Products & Ongoing Clinical Trials Overview 52
Table 90: Visca Device - Product Status 52
Table 91: Visca Device - Product Description 52
Table 92: Glossary 111

1.2 List of Figures
Figure 1: Haematology Analyzers - Pipeline Products by Stage of Development 10
Figure 2: Haematology Analyzers - Pipeline Products by Territory 11
Figure 3: Haematology Analyzers - Pipeline Products by Regulatory Path 12
Figure 4: Haematology Analyzers - Pipeline Products by Estimated Approval Date 13

【掲載企業】

Abbott Diagnostics
Analyticon Biotechnologies AG
Apollo Medical Devices LLC
Arkray, Inc.
Auer Precision
Axxin
Baebies, Inc.
Columbia University
DiaSorin S.p.A
Diatron Medical Instruments Limited
Drew Scientific Co. Limited
Ionu Biosystems
IRIS International, Inc.
Mindray Medical International Limited
Noninvasix, Inc.
Quotient Limited
Roche Diagnostics International Ltd.
SigTuple Technologies Private Limited
SpinChip Diagnostics AS
Sysmex Corporation
T2 Biosystems, Inc.
Tarabios
The University of British Columbia
University of Barcelona
Visca Corporation

【レポートのキーワード】

血液分析装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の血液分析装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月11日現在 219,328 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆